Related references
Note: Only part of the references are listed.Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer
A. Wu et al.
GENE THERAPY (2011)
Ipilimumab
Vernon K. Sondak et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy
Kozo Ohkusu-Tsukada et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
Elizabeth D. Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
CD4+ TH1 Cells Generated by Ii-PADRE DNA at Prime Phase Are Important to Induce Effectors and Memory CD8+ T Cells
Jae Yeo Park et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL
Stephanie L. Goff et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy
Thomas F. Gajewski
PIGMENT CELL & MELANOMA RESEARCH (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
Jacqueline D. Shields et al.
SCIENCE (2010)
Dendritic Cell-Based Vaccines for Pancreatic Cancer and Melanoma
James J. Mule
CANCER VACCINES (2009)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
Lotte Engell-Noerregaard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Ipilimumab: controversies in its development, utility and autoimmune adverse events
Jeffrey Weber
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Fusion of antigen to chemokine CCL20 or CXCL13 strategy to enhance DNA vaccine potency
Ji Hua Guo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Conditioning Vaccination Site With Irradiated MIP-3α-transfected Tumor Cells Enhances Efficacy of Dendritic Cell-based Cancer Vaccine
Neng-Yao Shih et al.
JOURNAL OF IMMUNOTHERAPY (2009)
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma
Paola Ghiorzo et al.
MELANOMA RESEARCH (2009)
The good and the bad of chemokines/chemokine receptors in melanoma
Ann Richmond et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model
Keiji Hirota et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Immunologic and clinical outcomes of a Randomized phase II trial of two multipeptide Vaccines for melanoma in the adjuvant setting
Craig L. Slingluff et al.
CLINICAL CANCER RESEARCH (2007)
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis
Antonio Manzo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
A crucial role for dendritic cell (DC) IL-10 in inhibiting successful DC-Based immunotherapy: Superior antitumor immunity against hepatocellular carcinoma evoked by DC devoid of IL-10
Yu-Xiao Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis
Monica Facco et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza
Javier Rangel-Moreno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication
Laura Novak et al.
MOLECULAR CANCER THERAPEUTICS (2007)
CC chemokine receptor 6 expression by B lymphocytes is essential for the development of isolated lymphoid follicles
Keely G. McDonald et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus
S. Barath et al.
LUPUS (2007)
Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains
Cristina R. Ferrone et al.
CLINICAL CANCER RESEARCH (2006)
Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentation
A Wankowicz-Kalinska et al.
MELANOMA RESEARCH (2006)
Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus
M Ichimura et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2006)
Systematic micro anatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis
A Manzo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT
M Hisada et al.
CANCER GENE THERAPY (2004)
Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector
A Terando et al.
CANCER GENE THERAPY (2004)
The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells
K Flanagan et al.
CELLULAR IMMUNOLOGY (2004)
Peptide vaccine trials for melanoma: preclinical background and clinical results
T Talebi et al.
SEMINARS IN CANCER BIOLOGY (2003)
Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses
L BenMohamed et al.
IMMUNOLOGY (2002)
Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues
PJ Skinner et al.
JOURNAL OF IMMUNOLOGY (2000)
Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo
S Sharma et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
